Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology
View Top Employees from Ortho Biotech Oncology Research and Development, A Unit of Cougar BiotechnologyWebsite | http://www.cougarbiotechnology.com |
Revenue | $10 million |
Employees | 5 (3 on RocketReach) |
Phone | (310) 943-8040 |
Fax | (310) 943-8059 |
Technologies |
JavaScript,
HTML,
PHP
+1 more
(view full list)
|
Industry | Pharmaceuticals, Biotechnology, Research, Healthcare |
Competitors | Biokine Therapeutics Ltd., Confluence Life Sciences, Puma Biotechnology, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies |
Looking for a particular Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology employee's phone or email?
The Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology annual revenue was $10 million in 2023.
Charles Eyler is the Vice President Finance and Treasurer of Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology.
3 people are employed at Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology.
Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology is based in New Brunswick, New Jersey.
The NAICS codes for Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology are [32541, 325, 3254, 541, 5417, 32, 54].
The SIC codes for Ortho Biotech Oncology Research and Development, A Unit of Cougar Biotechnology are [283, 28].